Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Beijing Herun Innovative Pharmaceutical Technology Development Co., Ltd., established on 2007-02-16, Business scope includes technology development,Technical Services,technical consulting,technology transfer;Economic and Trade Consulting;Investment Advisory;Sales of medical devicesIkind,cosmetic.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Sichuan Lubebei Biotechnology Co., Ltd., established on 2020-03-02, Business scope includes biotechnology development,technical consulting,technology transfer;R & D and sales of health care products;Health food research and development and sales(Business activities can only be carried out after obtaining relevant administrative licenses);Cosmetics research and development and sales;Medical Research(Does not include medical services);Import and export of goods and technology;Sales of agricultural and sideline products;Sales of prepackaged food and bulk food(Business activities can only be carried out after obtaining relevant administrative licenses).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Part of Gestion Socpra, Inc., SOCPRA-Sciences et Génie S.E.C. is a Canadian company located in Sherbrooke, QC, that manages research intellectual property.

Jilin Aodong Taonan Pharmaceutical Co., Ltd., established on 1998-02-06, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Class III medical device business;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Zelang Pharmaceutical Technology Co., Ltd., established on 2008-01-08, The business scope includes the development of plant extracts,processing,Sales and related technology transfer and service;medicine,food,Health food research and development;Cosmetic sales,Primary Agricultural Sales;cereals,vegetable,planting of flowers;Promotion of planting technology of Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sichuan Academy of Chinese Medicine Sciences, a subsidiary of Province of Sichuan, is a company headquartered in China that manufactures medicinal chemicals.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Anhui Biopeptide Industry Research Institute Co., Ltd., established on 2015-08-13, Business scope includes biotechnology,Technology research and development of medical technology,technical consulting,Technical Services,technology transfer,biologics,Chinese Herbal Medicine,Chinese herbal extract,Health and Physiotherapy Products,Food and Food Raw Materials,cosmetic,Class I and II medical device sales,Food and Food Raw Materials,pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).***

Shenzhen Ruixin Pharmaceutical Development Co., Ltd., established on 2004-03-31, Business scope includes general business items:biology,Technology development in medical technology,technical consulting,Technical service and transfer of own technological achievements;Daily chemicals,cosmetic,Wholesale and retail of dry goods from north and south;Class I medical equipment,In addition to the four pests medical equipment products,spray(pink)machine,Disinfectant,Office Supplies,Hygienic insecticide,Environmental protection products,Sales of environmental protection equipment;in the advertising business(law,Administrative regulations stipulate that the approval and registration of advertising business shall be carried out,It can be operated after separate approval and registration);Domestic Trade,Import and export of goods and technology;Logistics information consultation;Business Management Consulting;Corporate Image Planning;Network Technology Research,to develop;Internet of Things Technology Research,to develop.(Business operations involving pre-administrative licensing,Can operate only after obtaining pre-administrative licensing documents);Consulting and planning service;Conference and Exhibition Services;brand management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Culture and Entertainment Broker;vocational skills training.

Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, in multiple clinical studies. MARIO-275 is a global, randomized, placebo-controlled study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line and second line settings.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

Ningbo Dewo Biological Technology Co., Ltd., established on 2010-07-29, Business scope includes plant extracts,Pharmaceutical Intermediates,Research and development of biological fine chemical products,Production,food business,Cosmetics Wholesale,retail;Acquisition of agricultural products,Self-operated and agent import and export business of various goods and technologies(Except for goods and technologies that the state restricts the company to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Luoyang Huizhong Veterinary Medicine Co., Ltd., established on 1995-01-07, The business scope includes the production of veterinary drugs,Sales and Technology R&D,technology transfer,Technical Advisory Services(Operate with a valid license);Production of food and feed additives,Sales and Technology R&D(Operate with a valid license);Chemical Products(Free of Hazardous Chemicals,Flammable and explosive precursors);detergent(Free of Hazardous Chemicals),medical instruments(Operate with a valid license)promotion of;Production and sales of environmental protection equipment;Engaged in the import and export of goods or technology.

Natreon, Inc.is a company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.

Nanjing Tianyuan Peptide Pharmaceutical Technology Co., Ltd., established on 2014-09-03, Business scope includes medical technology,Research and development of biotechnology,technical consulting,technology transfer,Technical Services,Technology Promotion;Prepackaged food sales(Requires approval or license to operate);primary agricultural products,Food Additive Sales;Self-operated and agent import and export business of various commodities and technologies;Food processing technology research and development,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)